Relapsed or Refractory Hodgkin Lymphoma
specificA Hodgkin lymphoma that is resistant to treatment
11
Centers
2
Active Trials
$184K
Cancer Funding
Top Centers for Relapsed or Refractory Hodgkin Lymphoma(11)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive High-Volume Research Center | 71.4 |
| 2 | NCI Clinical High-Volume Research Center | 71.4 |
| 3 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 66.4 |
| 4 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive | 48.9 |
| 5 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive | 48.9 |
| 6 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 48.9 |
| 7 | NCI Comprehensive | 48.9 |
| 8 | Cleveland Clinic Cancer CenterCleveland, OH | 48.9 |
| 9 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive | 48.9 |
| 10 | Boston University Cancer CenterBoston, MA | 48.9 |
| 11 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive | 48.9 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →